BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10375613)

  • 1. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
    Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
    Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
    Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy,
    Bacci G; Ferrari S; Bertoni F; Picci P; Bacchini P; Longhi A; Donati D; Forni C; Campanacci L; Campanacci M
    Clin Orthop Relat Res; 2001 May; (386):186-96. PubMed ID: 11347833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
    Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
    Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
    Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
    Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
    Ekert H; Tiedemann K
    Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
    Meyers PA; Heller G; Vlamis V
    Cancer Treat Res; 1993; 62():309-22. PubMed ID: 7682091
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
    Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
    J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results after combined modality treatment for non-metastatic osteosarcoma.
    Aparicio J; Segura A; Montalar J; Garcerá S; Oltra A; Santaballa A; Yuste A; Pastor M; Munárriz B
    Med Oncol; 1999 Dec; 16(4):255-60. PubMed ID: 10618688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.
    Lewis IJ; Nooij MA; Whelan J; Sydes MR; Grimer R; Hogendoorn PC; Memon MA; Weeden S; Uscinska BM; van Glabbeke M; Kirkpatrick A; Hauben EI; Craft AW; Taminiau AH; ;
    J Natl Cancer Inst; 2007 Jan; 99(2):112-28. PubMed ID: 17227995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant chemotherapy of osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.